| 0 (0%) | 11-11 17:49 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.44 | 1-year : | 2.85 |
| Resists | First : | 2.08 | Second : | 2.44 |
| Pivot price | 1.77 |
|||
| Supports | First : | 1.74 | Second : | 1.52 |
| MAs | MA(5) : | 1.78 |
MA(20) : | 1.75 |
| MA(100) : | 1.33 |
MA(250) : | 0.88 |
|
| MACD | MACD : | 0  |
Signal : | 0 |
| %K %D | K(14,3) : | 47.6 |
D(3) : | 44.2 |
| RSI | RSI(14): 56.7 |
|||
| 52-week | High : | 2.08 | Low : | 0.37 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ LCTX ] has closed below upper band by 37.2%. Bollinger Bands are 11.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.86 - 1.87 | 1.87 - 1.88 |
| Low: | 1.75 - 1.76 | 1.76 - 1.77 |
| Close: | 1.81 - 1.82 | 1.82 - 1.83 |
Tue, 11 Nov 2025
How LCTX stock reacts to job market data - Quarterly Market Summary & Free Risk Controlled Daily Trade Plans - newser.com
Mon, 10 Nov 2025
Why LCTX stock could benefit from AI revolution - July 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
Mon, 10 Nov 2025
Will LCTX stock attract more institutional investors - Trade Risk Report & Community Verified Swing Trade Signals - newser.com
Mon, 10 Nov 2025
Will earnings trigger a reversal in LCTX - Market Sentiment Review & Long-Term Safe Return Strategies - newser.com
Sun, 09 Nov 2025
Will LCTX stock attract more institutional investors - Trend Reversal & Stepwise Trade Execution Plans - newser.com
Sat, 08 Nov 2025
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q3 2025 Earnings Call Transcript - Insider Monkey
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 228 (M) |
| Shares Float | 178 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 42.7 (%) |
| Shares Short | 27,240 (K) |
| Shares Short P.Month | 27,740 (K) |
| EPS | -0.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.2 |
| Profit Margin | 0 % |
| Operating Margin | -178.7 % |
| Return on Assets (ttm) | -13.2 % |
| Return on Equity (ttm) | -71.6 % |
| Qtrly Rev. Growth | 96.4 % |
| Gross Profit (p.s.) | -0.01 |
| Sales Per Share | 0.04 |
| EBITDA (p.s.) | -0.09 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -23 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -10.71 |
| PEG Ratio | 0 |
| Price to Book value | 8.66 |
| Price to Sales | 38.09 |
| Price to Cash Flow | -18.43 |
| Dividend | 0.05 |
| Forward Dividend | 0 |
| Dividend Yield | 3.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|